We have located links that may give you full text access.
Alleviating misclassified germline variants in underrepresented populations: a strategy using popmax.
PURPOSE: Germline variant interpretation often depends on population-matched control cohorts. This is not feasible for population-groups that are underrepresented in current population reference databases.
METHODS: We classify germline variants with population-matched controls for two ancestrally diverse cohorts of patients: 132 early-onset or familial CRC patients from Singapore (SG), and 100 early-onset CRC patients from the United States (US). The effects of using a population-mismatched control cohort are simulated by swapping the control cohorts used for each patient cohort, with or without the popmax computational strategy.
RESULTS: Population-matched classifications revealed a combined 62 pathogenic or likely pathogenic (P/LP) variants in 34 genes across both cohorts. Using a population-mismatched control cohort resulted in misclassification of non-P/LP variants as P/LP, driven by the absence of ancestry-specific rare variants in the control cohort. Popmax was more effective in alleviating misclassifications for the SG cohort than the US cohort.
CONCLUSION: Underrepresented population-groups can suffer from higher rates of false positive P/LP results. Popmax can partially alleviate these misclassifications, but its efficacy still depends on the degree with which the population-groups is represented in the control cohort.
METHODS: We classify germline variants with population-matched controls for two ancestrally diverse cohorts of patients: 132 early-onset or familial CRC patients from Singapore (SG), and 100 early-onset CRC patients from the United States (US). The effects of using a population-mismatched control cohort are simulated by swapping the control cohorts used for each patient cohort, with or without the popmax computational strategy.
RESULTS: Population-matched classifications revealed a combined 62 pathogenic or likely pathogenic (P/LP) variants in 34 genes across both cohorts. Using a population-mismatched control cohort resulted in misclassification of non-P/LP variants as P/LP, driven by the absence of ancestry-specific rare variants in the control cohort. Popmax was more effective in alleviating misclassifications for the SG cohort than the US cohort.
CONCLUSION: Underrepresented population-groups can suffer from higher rates of false positive P/LP results. Popmax can partially alleviate these misclassifications, but its efficacy still depends on the degree with which the population-groups is represented in the control cohort.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app